Healthcare | March 17, 2025
CKD cases surge to 16.38% in Indians aged 15+
Experts urge early detection & better access to care
Experts urge early detection & better access to care
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Subscribe To Our Newsletter & Stay Updated
